Download Files:
Ruplizumab
$300 – $1,250
Products Details
Product Description
– Ruplizumab (BG 9588) is a humanized monoclonal anti-CD40L (TNF Receptor) IgG1κ antibody. Ruplizumab has the potential for systemic lupus erythematosus disease research[1].
Web ID
– HY-P99315
Storage Temperature
– Store at -80°C for 2 years
Shipping
– Dry Ice
Applications
– COVID-19-immunoregulation
Molecular Formula
– N/A
References
– [1]Chris Chamberlain, et al. Repeated administration of dapirolizumab pegol in a randomised phase I study is well tolerated and accompanied by improvements in several composite measures of systemic lupus erythematosus disease activity and changes in whole blood transcriptomic profiles. Ann Rheum Dis. 2017 Nov;76(11):1837-1844.
CAS Number
– 220651-94-5
Molecular Weight
– N/A
Compound Purity
– 99.84
SMILES
– [Ruplizumab]
Clinical Information
– Phase 2
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– TNF Receptor
Pathway
– Apoptosis
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
